The finding that 7 acts as an agonist of GPR40, GPR55, and GPR119 offers a new therapeutic approach in the therapy of DM because of its potential beneficial effect beyond improvement of insulin secretion. This evidence concerns the gene FFAR1 and diabetes mellitus.